highperformr logo

IDEAYA Biosciences's Overview

Total employees168
HeadquartersSouth San Francisco
Founded2015

IDEAYA Biosciences (NASDAQ: IDYA) is a clinical-stage biotechnology company dedicated to pioneering precision medicine in oncology. The company focuses on the discovery and development of innovative targeted therapies for cancer patient populations identified through molecular diagnostics. IDEAYA's pipeline features multiple first-in-class and best-in-class synthetic lethality programs, aiming to exploit genetic vulnerabilities in tumors, as well as immuno-oncology therapies designed to enhance the body's immune response against cancer. Their approach integrates advanced biomarker strategies to identify patients most likely to benefit from their treatments, striving to deliver transformative medicines.

Where is IDEAYA Biosciences's Headquarters?

HQ Function

The headquarters serves as the primary center for research and development, clinical operations, corporate strategy, business development, and administrative functions, driving the company's mission in precision oncology.

Notable Features:

The facility is situated in the Shoreline Technology Park, a campus known for hosting life science companies. It provides modern laboratory and office spaces designed to support advanced scientific research and collaboration.

Work Culture:

The work culture at IDEAYA's headquarters is characterized by a strong emphasis on scientific innovation, collaboration, urgency, and a patient-centric approach. Employees are typically mission-driven, focusing on the development of impactful cancer therapies.

HQ Significance:

Its location in South San Francisco provides IDEAYA with access to a rich ecosystem of academic institutions, research organizations, skilled talent, and potential partners, fostering innovation and growth in the competitive biotech landscape.

Values Reflected in HQ: The headquarters' focus on advanced research facilities and its strategic location reflect IDEAYA's commitment to cutting-edge science, precision, innovation, and collaboration in its pursuit of novel cancer treatments.

Location:

While its primary operations and headquarters are in the US, IDEAYA Biosciences establishes a global presence through its clinical trial activities, which are often conducted across North America, Europe, and Asia-Pacific regions. This international reach is crucial for patient recruitment in various oncology indications. Additionally, collaborations with global pharmaceutical partners like GSK, and engagement with international research institutions, extend its operational footprint and support its drug discovery and development programs worldwide.

Street Address:

7000 Shoreline Court, Suite 350

City:

South San Francisco

State/Province:

California

Country:

USA

IDEAYA Biosciences's Global Presence

Buying Intent Signals for IDEAYA Biosciences

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of IDEAYA Biosciences

As of April 2025, IDEAYA Biosciences' leadership includes:

Yujiro S. Hata, M.B.A. - President and Chief Executive Officer
Paul A. Stone, J.D. - Chief Financial Officer
Michael P. White, Ph.D. - Chief Scientific Officer
Darrin M. Beaupre, M.D., Ph.D. - Chief Medical Officer
Jason L. Litten, J.D., Ph.D. - Chief Business Officer and General Counsel
Matthew G. Maurer, M.D. - Chief Development Officer, Hematology

Investors of IDEAYA Biosciences

IDEAYA Biosciences has been backed by several prominent investors over the years, including:

Boxer Capital, LLC
BlackRock, Inc.
The Vanguard Group, Inc.
RTW Investments, LP
Orbimed Advisors LLC
Adage Capital Management, L.P.

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

In the past 12-13 months, IDEAYA Biosciences strengthened its leadership with the appointment of Dr. Matthew G. Maurer as Chief Development Officer, Hematology, enhancing its capabilities in this key therapeutic area. No major executive departures have been publicly announced during this period.

New Appointments:

Matthew G. Maurer, M.D., Dr. Matthew G. Maurer joined IDEAYA Biosciences as Chief Development Officer, Hematology, bringing extensive experience to lead the company's efforts in this area.

Technology (Tech Stack) used by IDEAYA Biosciences

Discover the tools IDEAYA Biosciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

IDEAYA Biosciences Email Formats and Examples

IDEAYA Biosciences commonly uses the email format combining the first initial and last name. For example, for an employee named Jane Doe, the email address would likely be jdoe@ideayabio.com. This is a standard format in many biotech and pharmaceutical companies.

[first_initial][last]@ideayabio.com

Format

jdoe@ideayabio.com

Example

95%

Success rate

News and media

Ideaya Biosciences, Inc. / Business WireMay 31, 2024

IDEAYA Reports Positive Interim Phase 2 Clinical Data for Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma (MUM) at ASCO 2024

IDEAYA Biosciences announced positive interim results from its Phase 2 clinical trial evaluating darovasertib in combination with crizotinib for patients with metastatic uveal melanoma. The data, presented at ASCO, demonstrated encouraging confirmed overall response rates and median progression-free survival....more

Ideaya Biosciences, Inc. / GlobeNewswireMay 9, 2024

IDEAYA Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Update

IDEAYA reported its Q1 2024 financial results, highlighting a strong cash position and progress across its clinical pipeline, including updates on its MAT2A, PARG, and Pol Theta Helicase inhibitor programs. The company reiterated key upcoming milestones for its synthetic lethality pipeline....more

Ideaya Biosciences, Inc. / GlobeNewswireApril 3, 2024

IDEAYA and GSK Expand Collaboration to Include IDE397 and Niraparib Combination in MTAP-Deletion Bladder Cancer

IDEAYA Biosciences and GSK expanded their clinical collaboration to evaluate the combination of IDE397 (MAT2A inhibitor) and niraparib (PARP inhibitor) in a Phase 1/2 study for patients with MTAP-deletion bladder cancer, further broadening their joint efforts in precision oncology....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including IDEAYA Biosciences, are just a search away.